Adel S Girgis

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 28

Top Venues

Molecules (Basel, Switzerland)

RSC advances

Pharmaceuticals (Basel, Switzerland)

ChemMedChem

Cairo University Faculty of Science (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Cairo University Faculty of Science

Egypt

PHD :: Department of Chemistry

Publications

Sara M Hassan, Alyaa Farid, Siva S Panda, Mohamed S Bekheit, Holden Dinkins, Walid Fayad, Adel S Girgis
Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Sara M Hassan, Alyaa Farid, Siva S Panda, Mohamed S Bekheit, Holden Dinkins, Walid Fayad, Adel S Girgis
Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Dalia R Aboshouk, M Adel Youssef, Mohamed S Bekheit, Ahmad R Hamed, Adel S Girgis
Antineoplastic indole-containing compounds with potential VEGFR inhibitory properties. RSC advances 14 (9) (2024)
Sara M Hassan, Alyaa Farid, Siva S Panda, Mohamed S Bekheit, Holden Dinkins, Walid Fayad, Adel S Girgis
Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Dalia R Aboshouk, M Adel Youssef, Mohamed S Bekheit, Ahmad R Hamed, Adel S Girgis
Antineoplastic indole-containing compounds with potential VEGFR inhibitory properties. RSC advances 14 (9) (2024)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Siva S Panda, Marian N Aziz, Jacek Stawinski, Adel S Girgis
Azomethine Ylides-Versatile Synthons for Pyrrolidinyl-Heterocyclic Compounds. Molecules (Basel, Switzerland) 28 (2) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Siva S Panda, Adel S Girgis, Marian N Aziz, Mohamed S Bekheit
Spirooxindole: A Versatile Biologically Active Heterocyclic Scaffold. Molecules (Basel, Switzerland) 28 (2) (2023)
Siva S Panda, Marian N Aziz, Jacek Stawinski, Adel S Girgis
Azomethine Ylides-Versatile Synthons for Pyrrolidinyl-Heterocyclic Compounds. Molecules (Basel, Switzerland) 28 (2) (2023)
Adel S Girgis, Siva S Panda, Benson M Kariuki, Mohamed S Bekheit, Reham F Barghash, Dalia R Aboshouk
Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2. Molecules (Basel, Switzerland) 28 (18) (2023)
Siva S Panda, Marian N Aziz, Jacek Stawinski, Adel S Girgis
Azomethine Ylides-Versatile Synthons for Pyrrolidinyl-Heterocyclic Compounds. Molecules (Basel, Switzerland) 28 (2) (2023)
Siva S Panda, Adel S Girgis, Marian N Aziz, Mohamed S Bekheit
Spirooxindole: A Versatile Biologically Active Heterocyclic Scaffold. Molecules (Basel, Switzerland) 28 (2) (2023)
Siva S Panda, Marian N Aziz, Jacek Stawinski, Adel S Girgis
Azomethine Ylides-Versatile Synthons for Pyrrolidinyl-Heterocyclic Compounds. Molecules (Basel, Switzerland) 28 (2) (2023)
Siva S Panda, Adel S Girgis, Marian N Aziz, Mohamed S Bekheit
Spirooxindole: A Versatile Biologically Active Heterocyclic Scaffold. Molecules (Basel, Switzerland) 28 (2) (2023)
Adel S Girgis, Padraig D'Arcy, Dalia R Aboshouk, Mohamed S Bekheit
Synthesis and bio-properties of 4-piperidone containing compounds as curcumin mimics. RSC advances 12 (48) (2022)
Kailey A Wyman, Adel S Girgis, Pragnakiran S Surapaneni, Jade M Moore, Noura M Abo Shama, Sara H Mahmoud, Ahmed Mostafa, Reham F Barghash, Zou Juan, Radha D Dobaria, Ahmad J Almalki, Tarek S Ibrahim, Siva S Panda
Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach. Molecules (Basel, Switzerland) 27 (18) (2022)
Israa A Seliem, Siva S Panda, Adel S Girgis, Queen L Tran, Mona F Said, Mohamed S Bekheit, Anwar Abdelnaser, Soad Nasr, Walid Fayad, Ahmed A F Soliman, Rajeev Sakhuja, Tarek S Ibrahim, Zakaria K M Abdel-Samii, Amany M M Al-Mahmoudy
Development of Isatin-Based Schiff Bases Targeting VEGFR-2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies. ChemMedChem 17 (13) (2022)
M Adel Youssef, Siva S Panda, Riham A El-Shiekh, ElSayed M Shalaby, Dalia R Aboshouk, Walid Fayad, Nehmedo G Fawzy, Adel S Girgis
Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2'-pyrrolidine-3',3''-pyrrolidines]. RSC advances 10 (37) (2020)
Siva S Panda, Adel S Girgis, Hitesh H Honkanadavar, Riham F George, Aladdin M Srour
Synthesis of new ibuprofen hybrid conjugates as potential anti-inflammatory and analgesic agents. Future medicinal chemistry 12 (15) (2020)
Siva S Panda, Adel S Girgis, Bibhuti B Mishra, Mohamed Elagawany, Venkatasai Devarapalli, William F Littlefield, Ahmed Samir, Walid Fayad, Nehmedo G Fawzy, Aladdin M Srour, Riham M Bokhtia
Synthesis, computational studies, antimycobacterial and antibacterial properties of pyrazinoic acid-isoniazid hybrid conjugates. RSC advances 9 (35) (2019)
Nehmedo G Fawzy, Siva S Panda, Walid Fayad, ElSayed M Shalaby, Aladdin M Srour, Adel S Girgis
Synthesis, human topoisomerase IIα inhibitory properties and molecular modeling studies of anti-proliferative curcumin mimics. RSC advances 9 (58) (2019)
Heba T Abdel-Mohsen, Adel S Girgis, Abeer E E Mahmoud, Mamdouh M Ali, Hoda I El Diwani
New 2,4-disubstituted-2-thiopyrimidines as VEGFR-2 inhibitors: Design, synthesis, and biological evaluation. Archiv der Pharmazie 352 (11) (2019)
Israa A Seliem, Siva S Panda, Adel S Girgis, Yosra I Nagy, Riham F George, Walid Fayad, Nehmedo G Fawzy, Tarek S Ibrahim, Amany M M Al-Mahmoudy, Rajeev Sakhuja, Zakaria K M Abdel-Samii
Design, synthesis, antimicrobial, and DNA gyrase inhibitory properties of fluoroquinolone-dichloroacetic acid hybrids. Chemical biology & drug design 95 (2) (2019)
Marian N Aziz, Siva S Panda, ElSayed M Shalaby, Nehmedo G Fawzy, Adel S Girgis
Facile synthetic approach towards vasorelaxant active 4-hydroxyquinazoline-4-carboxamides. RSC advances 9 (49) (2019)

Adel S Girgis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Adel S Girgis